Cue Biopharma, Inc. CUE
19.84 USD -1.02 (-4.89%)
At closeNov 4, 2026, 4:10 PM EST
18.50 -1.34 -6.75%
After hours · Nov 4, 4:10 PM ET
18.30 Day range 20.98
4.98 52-week range 45.50
- YTD
- +116.83%
- 1 year
- -8.28%
Analyst view
Price target (mean) 3.60 -81.9% downside
Now 19.84
- Target (low)
- 2.00
- Target (mean)
- 3.60
- Target (high)
- 6.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.145 | -0.15 – -0.14 | -0.29 | +50.0% | 1.70M | -6.6% | 2 |
| Next quarter | -0.15 | -0.17 – -0.13 | -0.25 | +40.0% | 1.27M | -26.2% | 2 |
| Current year | -0.755 | -0.77 – -0.74 | -1.11 | +32.0% | 9.41M | +71.4% | 2 |
| Next year | -0.57 | -0.60 – -0.54 | -0.755 | +24.5% | 10.45M | +11.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2024 | Stifel | Maintained | Buy | Buy |
| Jul 26, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 26, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Apr 9, 2024 | Stifel | Maintained | Buy | Buy |
| Apr 9, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 3, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Mar 13, 2024 | Jefferies | Initiated | — | Buy |
| Nov 6, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 15, 2023 | Stifel | Reiterated | Buy | Buy |
| May 15, 2023 | JMP Securities | Reiterated | Outperform | Outperform |
| Mar 22, 2023 | Stifel | Maintained | — | Buy |
| Mar 22, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Nov 21, 2022 | Piper Sandler | Initiated | — | Overweight |
| Aug 24, 2022 | Oppenheimer | Maintained | — | Outperform |
| Mar 21, 2022 | Oppenheimer | Maintained | — | Outperform |
| Mar 18, 2022 | Craig-Hallum | Maintained | — | Buy |
| Nov 24, 2020 | Berenberg | Initiated | — | Buy |
| May 20, 2020 | Stifel | Maintained | — | Buy |
| May 20, 2020 | Oppenheimer | Maintained | — | Outperform |
| Apr 21, 2020 | Stifel | Maintained | — | Buy |
| Apr 9, 2020 | Stifel | Initiated | — | Buy |
| Mar 6, 2020 | JMP Securities | Maintained | — | Outperform |
| Feb 25, 2020 | Oppenheimer | Initiated | — | Outperform |
| Jan 28, 2020 | BTIG | Initiated | — | Buy |
| Jan 22, 2020 | JMP Securities | Initiated | — | Market Outperform |
| Jul 26, 2019 | Baird | Initiated | — | Outperform |